Free Trial

Clearside Biomedical (CLSD) Short Interest Ratio & Short Volume

Clearside Biomedical logo
$0.95 -0.08 (-7.77%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.98 +0.03 (+3.16%)
As of 03/28/2025 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clearside Biomedical Short Interest Data

Clearside Biomedical (CLSD) has a short interest of 735,600 shares, representing 1.07% of the float (the number of shares available for trading by the public). This marks a -4.14% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 355,754 shares to cover all short positions.

Current Short Interest
735,600 shares
Previous Short Interest
767,400 shares
Change Vs. Previous Month
-4.14%
Dollar Volume Sold Short
$654,463.32
Short Interest Ratio
3.0 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
75,844,000 shares
Short Percent of Float
1.07%
Today's Trading Volume
289,511 shares
Average Trading Volume
355,754 shares
Today's Volume Vs. Average
81%
Short Selling Clearside Biomedical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Clearside Biomedical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLSD Short Interest Over Time

CLSD Days to Cover Over Time

CLSD Percentage of Float Shorted Over Time

Remove Ads

Clearside Biomedical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025735,600 shares $654,463.32 -4.1%1.1%3 $0.89
2/28/2025767,400 shares $659,733.78 +34.3%1.1%3 $0.86
2/15/2025571,300 shares $611,291.00 -26.6%0.8%2.3 $1.07
1/31/2025777,800 shares $723,354.00 +2.5%N/A3.1 $0.93
1/15/2025758,900 shares $713,366.00 +2.3%N/A2.7 $0.94
12/31/2024741,700 shares $704,615.00 -32.6%N/A1.1 $0.95
12/15/20241,100,000 shares $1.12 million -17.9%N/A1.5 $1.02
11/30/20241,340,000 shares $1.41 million -11.8%N/A1.8 $1.05
11/15/20241,520,000 shares $1.50 million -13.6%N/A2 $0.99
10/31/20241,760,000 shares $1.80 million -9.7%N/A2.4 $1.02
10/15/20241,950,000 shares $2.16 million +646.6%N/A2.7 $1.11
9/30/2024261,200 shares $331,724.00 -4.5%N/A0.5 $1.27
9/15/2024273,400 shares $336,282.00 -18.4%N/A1.1 $1.23
8/31/2024335,200 shares $338,552.00 +86.0%N/A1.5 $1.01
8/15/2024180,200 shares $190,111.00 -12.9%N/A1.1 $1.06
7/31/2024206,900 shares $235,866.00 +76.8%N/A1.1 $1.14
7/15/2024117,000 shares $145,080.00 -48.4%N/A0.7 $1.24
6/30/2024226,900 shares $294,970.00 +17.5%N/A1.2 $1.30
6/15/2024193,100 shares $229,789.00 -30.0%N/A0.8 $1.19
5/31/2024275,800 shares $386,120.00 -19.7%N/A0.9 $1.40
5/15/2024343,300 shares $453,156.00 +1.4%N/A0.9 $1.32
4/30/2024338,700 shares $426,762.00 +27.7%N/A0.9 $1.26
4/15/2024265,300 shares $342,237.00 +18.3%N/A0.7 $1.29
3/31/2024224,300 shares $343,179.00 -34.0%N/A0.6 $1.53
3/15/2024339,900 shares $581,229.00 +23.4%N/A1 $1.71
2/29/2024275,400 shares $385,560.00 +70.1%N/A1 $1.40
2/15/2024161,900 shares $197,518.00 -12.0%N/A0.9 $1.22
1/31/2024183,900 shares $229,875.00 -12.8%0.4%1 $1.25
1/15/2024210,800 shares $305,660.00 +11.1%0.4%1.1 $1.45
12/31/2023189,700 shares $221,949.00 -43.8%0.4%1 $1.17
12/15/2023337,700 shares $347,831.00 +19.4%0.7%2.1 $1.03
11/30/2023282,900 shares $285,729.00 -3.4%0.6%2.3 $1.01
11/15/2023292,900 shares $281,184.00 +0.8%0.6%2.5 $0.96
10/31/2023290,600 shares $210,568.76 -15.7%0.6%2.3 $0.72
10/15/2023344,500 shares $296,614.50 -1.7%0.7%3.6 $0.86
9/30/2023350,500 shares $304,899.95 -8.5%0.7%3.3 $0.87
9/15/2023382,900 shares $315,892.50 +45.4%0.8%3.4 $0.83
8/31/2023263,400 shares $239,694.00 +20.2%0.5%2.1 $0.91
8/15/2023219,200 shares $217,008.00 -17.5%0.4%1.8 $0.99
7/31/2023265,700 shares $310,869.00 -22.4%0.5%2.2 $1.17
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
7/15/2023342,400 shares $410,880.00 -17.4%0.7%2.7 $1.20
6/30/2023414,400 shares $464,128.00 -15.0%0.8%3.3 $1.12
6/15/2023487,600 shares $682,640.00 -22.1%1.0%2.9 $1.40
5/31/2023626,100 shares $676,188.00 +10.2%1.2%3.6 $1.08
5/15/2023568,400 shares $608,188.00 +102.8%1.1%3.1 $1.07
4/30/2023280,300 shares $283,103.00 +4.0%0.6%1.5 $1.01
4/15/2023269,600 shares $296,560.00 -19.6%0.5%1.3 $1.10
3/31/2023335,500 shares $348,920.00 -4.5%0.7%1.5 $1.04
3/15/2023351,200 shares $344,176.00 +8.7%0.7%1.5 $0.98
2/28/2023323,100 shares $400,644.00 +0.1%0.7%1.4 $1.24
2/15/2023322,700 shares $432,418.00 +30.5%0.7%1.3 $1.34
1/31/2023247,200 shares $348,552.00 +15.4%0.5%0.8 $1.41
1/15/2023214,300 shares $336,451.00 -48.3%0.4%0.8 $1.57
12/30/2022414,600 shares $464,352.00 +3.8%0.8%1.6 $1.12
12/15/2022399,500 shares $483,395.00 +5.9%0.8%1.8 $1.21
11/30/2022377,100 shares $456,291.00 -32.6%0.8%2 $1.21
11/15/2022559,600 shares $789,036.00 +4.8%1.2%3 $1.41
10/31/2022534,100 shares $608,874.00 +7.7%1.1%4.1 $1.14
10/15/2022495,800 shares $565,212.00 +4.8%1.0%3.9 $1.14
9/30/2022473,100 shares $534,603.00 -9.1%1.0%3.6 $1.13
9/15/2022520,300 shares $686,796.00 +11.0%1.1%3.8 $1.32
8/31/2022468,600 shares $641,982.00 +8.3%1.0%3.1 $1.37
8/15/2022432,700 shares $666,358.00 -7.0%0.9%2.8 $1.54
7/31/2022465,100 shares $716,254.00 -20.8%1.0%2.8 $1.54
7/15/2022587,100 shares $1.06 million -10.0%1.2%2.8 $1.81
6/30/2022652,100 shares $958,587.00 -30.9%1.4%2.8 $1.47
6/15/2022944,000 shares $1.26 million -24.5%2.0%3.6 $1.34
5/31/20221,250,000 shares $1.63 million -24.7%2.6%1.4 $1.30
5/15/20221,660,000 shares $2.34 million No Change3.4%1.7 $1.41
4/30/20221,660,000 shares $2.54 million -11.7%3.4%1.7 $1.53
4/15/20221,880,000 shares $3.91 million +36.2%3.9%1.8 $2.08
3/31/20221,380,000 shares $3.16 million -46.7%2.9%1.4 $2.29
3/15/20222,590,000 shares $6.45 million +102.3%5.4%2.5 $2.49
2/28/20221,280,000 shares $2.04 million -3.8%2.7%3 $1.60
2/15/20221,330,000 shares $2.26 million -7.0%2.8%3.1 $1.70
1/31/20221,430,000 shares $2.79 million +28.8%3.0%3.3 $1.95
1/15/20221,110,000 shares $2.48 million -9.0%N/A2.3 $2.23
12/31/20211,220,000 shares $3.36 million -3.2%2.6%2.6 $2.75
12/15/20211,260,000 shares $3.70 million +18.9%2.7%2.4 $2.94
11/30/20211,060,000 shares $3.89 million +1.0%2.2%2.1 $3.67
11/15/20211,050,000 shares $5.07 million -52.3%2.2%2 $4.83
10/29/20212,200,000 shares $12.01 million +81.8%4.6%4 $5.46
10/15/20211,210,000 shares $6.82 million +28.4%2.6%2.1 $5.64
9/30/2021942,500 shares $5.66 million -0.9%2.0%1.6 $6.00
9/15/2021951,200 shares $6.25 million -36.2%2.0%1 $6.57
8/31/20211,490,000 shares $10.27 million -32.6%3.2%0.5 $6.89
8/13/20212,210,000 shares $12.57 million +5.7%4.7%0.7 $5.69
7/30/20212,090,000 shares $10.28 million +11.2%4.7%0.7 $4.92
7/15/20211,880,000 shares $9.95 million +18.2%4.2%0.6 $5.29
6/30/20211,590,000 shares $7.74 million +43.2%3.6%0.5 $4.87
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
6/15/20211,110,000 shares $4.62 million +37.0%2.5%0.4 $4.16
5/28/2021810,500 shares $2.08 million -6.5%1.9%3.6 $2.57
5/14/2021866,500 shares $2.01 million -9.7%N/A3.2 $2.32
4/30/2021959,100 shares $2.86 million -0.6%N/A2.8 $2.98
4/15/2021965,200 shares $2.58 million +1.9%N/A2.3 $2.67
3/31/2021947,500 shares $2.22 million +44.3%N/A1.6 $2.34
3/15/2021656,600 shares $2.00 million +53.2%N/A0.8 $3.05
2/26/2021428,700 shares $1.39 million -16.9%N/A0.5 $3.25
2/12/2021515,600 shares $1.99 million +29.1%N/A0.6 $3.86
1/29/2021399,400 shares $1.32 million -37.9%N/A0.5 $3.31
1/15/2021643,600 shares $2.70 million -22.7%N/A0.9 $4.20
12/31/2020832,500 shares $1.93 million -16.7%N/A1.4 $2.32
12/15/2020999,700 shares $2.08 million -16.7%2.8%4.1 $2.08
11/30/20201,200,000 shares $2.34 million -12.4%3.3%6 $1.95
11/15/20201,370,000 shares $2.26 million -5.5%3.8%8.8 $1.65
10/30/20201,450,000 shares $2.03 million -0.7%4.2%7.9 $1.40
10/15/20201,460,000 shares $2.13 million -4.6%4.3%6.2 $1.46
9/30/20201,530,000 shares $2.36 million -8.4%4.5%5.7 $1.54
9/15/20201,670,000 shares $2.77 million +3.1%4.9%5.8 $1.66
8/31/20201,620,000 shares $2.79 million -10.5%4.7%4.7 $1.72
8/14/20201,810,000 shares $3.24 million +11.0%5.3%4.6 $1.79
7/31/20201,630,000 shares $2.67 million -1.8%4.8%4 $1.64
7/15/20201,660,000 shares $2.79 million +5.7%5.0%4.2 $1.68
6/30/20201,570,000 shares $2.95 million -0.6%4.7%3.8 $1.88
6/15/20201,580,000 shares $3.24 million +4.0%4.8%3.8 $2.05
5/29/20201,520,000 shares $2.83 million +2.0%4.6%3.2 $1.86
5/15/20201,490,000 shares $2.95 million -0.7%4.5%3 $1.98
4/30/20201,500,000 shares $2.97 million -10.2%4.5%2.9 $1.98
4/15/20201,670,000 shares $4.02 million -10.2%5.0%2.4 $2.41
3/31/20201,860,000 shares $4.09 million -28.7%5.6%2 $2.20

CLSD Short Interest - Frequently Asked Questions

What is Clearside Biomedical's current short interest?

Short interest is the volume of Clearside Biomedical shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 735,600 shares of CLSD short. 1.07% of Clearside Biomedical's shares are currently sold short. Learn More on Clearside Biomedical's current short interest.

What is a good short interest ratio for Clearside Biomedical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSD shares currently have a short interest ratio of 3.0. Learn More on Clearside Biomedical's short interest ratio.

Which institutional investors are shorting Clearside Biomedical?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clearside Biomedical: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Clearside Biomedical?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.07% of Clearside Biomedical's floating shares are currently sold short.

Is Clearside Biomedical's short interest increasing or decreasing?

Clearside Biomedical saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 735,600 shares, a decrease of 4.1% from the previous total of 767,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Clearside Biomedical's short interest compare to its competitors?

1.07% of Clearside Biomedical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Clearside Biomedical: Cardiff Oncology, Inc. (28.30%), UroGen Pharma Ltd. (27.63%), Atea Pharmaceuticals, Inc. (4.15%), Immutep Limited (3.37%), enGene Holdings Inc. (0.19%), DiaMedica Therapeutics Inc. (0.67%), Foghorn Therapeutics Inc. (3.50%), Bright Minds Biosciences Inc. (2.21%), 2seventy bio, Inc. (6.98%), Olema Pharmaceuticals, Inc. (18.82%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Clearside Biomedical stock?

Short selling CLSD is an investing strategy that aims to generate trading profit from Clearside Biomedical as its price is falling. CLSD shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Clearside Biomedical?

A short squeeze for Clearside Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSD, which in turn drives the price of the stock up even further.

How often is Clearside Biomedical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSD, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:CLSD) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners